<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Bispecific Antibody Evaluation via CD3E Transgenic Model

Preclinical development and evaluation of T cell-redirecting antibodies is often blocked by a lack of appropriate in vivo models. These bispecific antibodies physically link tumour and T cells, usually binding to tumour associated antigens and CD3ε.